BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17951225)

  • 1. Outcomes research in cancer symptom management trials: the Radiation Therapy Oncology Group (RTOG) conceptual model.
    Bruner DW
    J Natl Cancer Inst Monogr; 2007; (37):12-5. PubMed ID: 17951225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life measurement in symptom management trials.
    Ganz PA; Goodwin PJ
    J Natl Cancer Inst Monogr; 2007; (37):47-52. PubMed ID: 17951231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life.
    Wiklund I
    Fundam Clin Pharmacol; 2004 Jun; 18(3):351-63. PubMed ID: 15147288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative.
    Garcia SF; Cella D; Clauser SB; Flynn KE; Lad T; Lai JS; Reeve BB; Smith AW; Stone AA; Weinfurt K
    J Clin Oncol; 2007 Nov; 25(32):5106-12. PubMed ID: 17991929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.
    Willke RJ; Burke LB; Erickson P
    Control Clin Trials; 2004 Dec; 25(6):535-52. PubMed ID: 15588741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of patient-reported outcomes in cancer clinical trials.
    Gotay CC; Kawamoto CT; Bottomley A; Efficace F
    J Clin Oncol; 2008 Mar; 26(8):1355-63. PubMed ID: 18227528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translating the science of patient-reported outcomes assessment into clinical practice.
    Osoba D
    J Natl Cancer Inst Monogr; 2007; (37):5-11. PubMed ID: 17951224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program.
    Buchanan DR; O'Mara AM; Kelaghan JW; Minasian LM
    J Clin Oncol; 2005 Jan; 23(3):591-8. PubMed ID: 15659506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in oncology trials: a clinical guide.
    Movsas B
    Semin Radiat Oncol; 2003 Jul; 13(3):235-47. PubMed ID: 12903013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should health-related quality of life be measured in cancer symptom management clinical trials? Lessons learned using the functional assessment of cancer therapy.
    Cella D; Wagner L; Cashy J; Hensing TA; Yount S; Lilenbaum RC
    J Natl Cancer Inst Monogr; 2007; (37):53-60. PubMed ID: 17951232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in what quality-of-life instruments measure.
    Ferrans CE
    J Natl Cancer Inst Monogr; 2007; (37):22-6. PubMed ID: 17951227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
    Sloan JA; Berk L; Roscoe J; Fisch MJ; Shaw EG; Wyatt G; Morrow GR; Dueck AC;
    J Clin Oncol; 2007 Nov; 25(32):5070-7. PubMed ID: 17991923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes research in cancer clinical trial cooperative groups: the RTOG model.
    Bruner DW; Movsas B; Konski A; Roach M; Bondy M; Scarintino C; Scott C; Curran W
    Qual Life Res; 2004 Aug; 13(6):1025-41. PubMed ID: 15287270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring patient-oriented outcomes in palliative care: functionality and quality of life.
    Granda-Cameron C; Viola SR; Lynch MP; Polomano RC
    Clin J Oncol Nurs; 2008 Feb; 12(1):65-77. PubMed ID: 18258576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality-of-life outcomes in oncology.
    Siddiqui F; Kachnic LA; Movsas B
    Hematol Oncol Clin North Am; 2006 Feb; 20(1):165-85. PubMed ID: 16580562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing health related quality of life in medicine. An overview over concepts, methods and applications in international research.
    Bullinger M
    Restor Neurol Neurosci; 2002; 20(3-4):93-101. PubMed ID: 12454358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported outcomes in cancer: a review of recent research and policy initiatives.
    Lipscomb J; Gotay CC; Snyder CF
    CA Cancer J Clin; 2007; 57(5):278-300. PubMed ID: 17855485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom burden: multiple symptoms and their impact as patient-reported outcomes.
    Cleeland CS
    J Natl Cancer Inst Monogr; 2007; (37):16-21. PubMed ID: 17951226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels.
    Gondek K; Sagnier PP; Gilchrist K; Woolley JM
    J Clin Oncol; 2007 Nov; 25(32):5087-93. PubMed ID: 17991926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conceptual issues in symptom clusters research and their implications for quality-of-life assessment in patients with cancer.
    Miaskowski C; Aouizerat BE; Dodd M; Cooper B
    J Natl Cancer Inst Monogr; 2007; (37):39-46. PubMed ID: 17951230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.